ロード中...
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
BACKGROUND: Circulating cell-free DNA (cfDNA) has recently been recognized as a resource for biomarkers of cancer progression, treatment response, and drug resistance. However, few have demonstrated the usefulness of cfDNA for early detection of cancer. Although aberrant DNA methylation in cfDNA has...
保存先:
| 出版年: | Breast Cancer Res |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5168705/ https://ncbi.nlm.nih.gov/pubmed/27993161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0788-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|